These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Captopril - a genuine innovation. Drug Ther Bull; 1982 Feb; 20(4):13-5. PubMed ID: 6277587 [No Abstract] [Full Text] [Related]
3. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related]
4. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension]. Kabat M; Makowiecka-Cieśla M Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092 [No Abstract] [Full Text] [Related]
5. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs]. Lazowski J Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537 [No Abstract] [Full Text] [Related]
6. [Use of captopril in arterial hypertension with a stable and malignant course]. Lordkipanidze NL Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432 [No Abstract] [Full Text] [Related]
7. Captopril for hypertension. Med Lett Drugs Ther; 1980 May; 22(9):39-40. PubMed ID: 6245345 [No Abstract] [Full Text] [Related]
8. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II]. Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350 [No Abstract] [Full Text] [Related]
9. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure. Lee CL; MacDonald GJ; Walsh WF Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831 [No Abstract] [Full Text] [Related]
12. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension. Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)]. Guerrera G; Melina D Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570 [No Abstract] [Full Text] [Related]
14. Treatment of hypertension with angiotensin converting enzyme inhibitors. Johnston CI; McGrath BP; Matthews PG; Jackson B Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036 [No Abstract] [Full Text] [Related]
15. Development and pharmacology of angiotensin converting enzyme inhibitors. Antonaccio MJ J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887 [TBL] [Abstract][Full Text] [Related]
16. [Hypotensive effects of angiotensin I converting enzyme inhibitor, and relationship between kallikrein-kinin system and renin-angiotensin-aldosterone system]. Mizuno K; Gotoh M; Haruyama K; Ikeda K; Hashimoto S; Fukuchi S Nihon Jinzo Gakkai Shi; 1983 Jan; 25(1):59-66. PubMed ID: 6341658 [No Abstract] [Full Text] [Related]
17. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension]. Stanek B; Templ H; Pohanka E; Silberbauer K Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046 [No Abstract] [Full Text] [Related]
18. [Captopril (Capoten). A new antihypertensive agent blocking the renin-angiotensin system]. Rasmussen S; Jensen G; Giese J Ugeskr Laeger; 1983 May; 145(22):1695-9. PubMed ID: 6349075 [No Abstract] [Full Text] [Related]
19. [Renin-angiotensin system and arterial hypertension. Mechanism of action of beta-blockers and captopril]. Staroukine M; Giot JM; Jacobs W; Verniory A Bull Mem Acad R Med Belg; 1982; 137(12):723-36. PubMed ID: 6136306 [No Abstract] [Full Text] [Related]